KR970010460B1 - Separation method for 5-(3-(2-4-dihydroxy phenyl)propyl)-3,4- bis (3-methyl-2-butenyl)-1,2-benzenediol - Google Patents

Separation method for 5-(3-(2-4-dihydroxy phenyl)propyl)-3,4- bis (3-methyl-2-butenyl)-1,2-benzenediol Download PDF

Info

Publication number
KR970010460B1
KR970010460B1 KR1019940007603A KR19940007603A KR970010460B1 KR 970010460 B1 KR970010460 B1 KR 970010460B1 KR 1019940007603 A KR1019940007603 A KR 1019940007603A KR 19940007603 A KR19940007603 A KR 19940007603A KR 970010460 B1 KR970010460 B1 KR 970010460B1
Authority
KR
South Korea
Prior art keywords
butenyl
bis
methyl
propyl
benzenediol
Prior art date
Application number
KR1019940007603A
Other languages
Korean (ko)
Other versions
KR950029247A (en
Inventor
장동일
이병곤
조재훈
전체옥
Original Assignee
주식회사 태평양
한동근
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 태평양, 한동근 filed Critical 주식회사 태평양
Priority to KR1019940007603A priority Critical patent/KR970010460B1/en
Publication of KR950029247A publication Critical patent/KR950029247A/en
Application granted granted Critical
Publication of KR970010460B1 publication Critical patent/KR970010460B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/68Purification; separation; Use of additives, e.g. for stabilisation
    • C07C37/685Processes comprising at least two steps in series
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings

Abstract

Process for separating 5- (3- (2- 4- dehydroxy phenyl) prophyl) - 3,4- bis (3- methyl - 2- butenyl)- 1,2- benzendiol which is used to make compositions for whitening skin, antioxidizing or antibrowning comprises the steps of: extracting from bark or velamen of paper mulberry by using a polar solvent; condensing the extract; partitioning it with a oil-soluble solvent and water; chromatographing the fraction of the oil-soluble solvent layer on Sephadex LH-20, a column packed silica and a reversed-phase column, subsequently to separate and refine the final compound.

Description

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 분리방법 및 그를 함유하는 조성물Separation method of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol and composition containing the same

제1도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의1H-NMR 스펙트럼이다.1 is a 1 H-NMR spectrum of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol .

제2도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의13C-NMR 스펙트럼이다.2 is a 13 C-NMR spectrum of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol .

제3도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 IR 스펙트럼이다.3 is an IR spectrum of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol.

제4도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 MS 스펙트럼이다.4 is an MS spectrum of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol.

제5도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 UV 스펙트럼이다.5 is the UV spectrum of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol.

제6도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 티로시나제 활성억제작용을 나타내는 그래프이다.FIG. 6 shows the tyrosinase activity inhibitory activity of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol It is a graph.

제7도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 항산화 작용을 나타내는 그래프이다.7 is a graph showing the antioxidant activity of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol .

제8도는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 폴리페놀옥시다제 활성억제 작용을 나타내는 그래프이다.8 shows polyphenol oxidase activity inhibition of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol Graph showing the action.

본 발명은 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 분리 정제하는 방법 및 이렇게 분리한 물질의 용도에 관한 것이다.The present invention provides a method for separating and purifying 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol and so It relates to the use of the separated material.

보다 상세하게는, 본 발명은 닥나무속(Broussonetia) 식물의 수피(樹皮)나 근피(根皮)에서 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 분리 정제하는 방법 및 이 화합물을 유효성분으로 함유하는 피부미백 조성물, 항산화 조성물 및 갈변방지용 조성물에 관한 것이다.More specifically, the present invention provides 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis () in bark or root bark of Broussonetia plants. It relates to a method for separating and purifying 3-methyl-2-butenyl) -1,2-benzenediol and a skin lightening composition, an antioxidant composition and a browning prevention composition containing the compound as an active ingredient.

피부가 검게 되는 것은 내적, 외적 요인에 대한 피부세포의 반응에 의하여 발생하는데, 현상적으로는 피부표피조직의 기저층에 있는 멜라노사이트라는 세포에서 티로신에 티로시나제라는 효소가 작용하고 뒤따르는 일련의 산화과정을 통해 멜라닌이라는 중합체가 과량 만들어져 피부에 축적되는 것이다. 티로시나제는 아미노산의 일종인 티로신을 멜라닌 중합체 생성의 중간산물인 도파, 도파퀴논으로 만드는 피부의 흑화과정에서 가장 중요하게 작용하는 효소이다. 이렇듯이 멜라닌 생성과정이 티로시나제의 작용과 도파퀴논 이후의 일련의 멜라닌 중합체로의 산화과정이기 때문에 멜라닌 생성방지의 물질들은 티로시나제 활성 억제효과를 갖거나 항산화 효과를 갖는 물질이다.The blackening of the skin is caused by the reaction of skin cells to internal and external factors. Phenomenologically, a series of oxidation processes, followed by the action of tyrosine and tyrosinase on tyrosine in cells called melanocytes in the basal layer of the skin's epidermal tissue. This creates an excess of melanin and accumulates in the skin. Tyrosinase is the most important enzyme in the skin's blackening process that makes tyrosine, an amino acid, into dopa and dopaquinone, the intermediate products of melanin polymer production. As the melanin production process is the action of tyrosinase and oxidation of melanin polymer after dopaquinone, the melanin-preventing substances have a tyrosinase inhibitory effect or an antioxidant effect.

흑화 피부나, 기미 주근깨 등의 색소성 피부질환의 개선, 치료에 대한 욕구는 특히 여성에게 있어서는 아주 크다. 실제로 아스콜빈산, 코지산, 글루타치온, 히드로퀴논 등은 티로시나제 활성 억제 효과나 항산화효과가 있어 이들을 함유시킨 미백화장료나 약품들이 시판되고 있으나 아스콜빈산, 히드로퀴논, 클루타치온 등은 매우 불안정하고 쉽게 산화되므로 제형상에서 쉽게 변색되거나 변질되는 문제점이 있다. 글루타치온은 자체의 특이한 냄새를 갖고 있으며 또 코지산은 미백 효과면에서 만족할만한 정도가 아니며 아스콜빈산, 히드로퀴논 등은 피부부작용이 심하여 사용상에 많은 제한을 받아왔다.The desire for improvement and treatment of pigmented skin diseases such as blackened skin and freckle freckles is particularly great for women. Actually, ascorbic acid, kojic acid, glutathione, hydroquinone, etc. have tyrosinase inhibitory effect or antioxidant effect, so whitening cosmetics or drugs containing them are commercially available, but ascorbic acid, hydroquinone, glutathione, etc. are very unstable and easily oxidized. There is a problem of discoloration or deterioration easily in the formulation. Glutathione has its own peculiar smell, and kojic acid is not satisfactory in terms of whitening effect, and ascorbic acid and hydroquinone have been severely restricted in use due to severe skin side effects.

또 최근에는 천연물중에서 미백효과를 갖는 물질을 탐색하는 경향이 두드러지며 상백피(일본 공개특허 소 55-44375, 소 64-26507, 소 64-83009, 평 1-256587, 감초(일본 공개특허 소 60-214721, 소 63-23809, 소 64-63506, 평 1-149706), 작약(일본 공개특허 소 61-246109), 계피(일본 공개특허 63-30403), 고삼, 호장근, 오매 만형자, 사누유, 호고초 등의 식물 추출물에 멜라닌 생성 억제효과가 있음이 이미 보고 되어 있다. 그러나 이들 추출물들은 색깔을 띄고 있어 배합상에서의 문제도 있고 유효성분을 정확히 알지 못하기 때문에 제품제조시 동일한 정도의 효과를 기대하기 어렵고 추출물내의 원하지 않는 성분이 함유되어 있을 가능성도 배제할 수 없다.In recent years, the tendency to search for substances having a whitening effect in natural products is prominent, and it has been found that sangbaekpi (Japanese Patent Application No. 55-44375, Cow 64-26507, Cow 64-83009, Pyeong 1-256587, Licorice (Japanese Patent Application Laid-Open No. 60-60). 214721, small 63-23809, small 64-63506, flat 1-149706), peony (Japanese Patent Laid-Open No. 61-246109), cinnamon (Japanese Patent Laid-Open No. 63-30403), red ginseng, Ho Jang-geun, oman manza, Sanyu It has already been reported to inhibit melanin production in plant extracts, eg, Hogo vinegar, etc. However, these extracts have color effects, so they have problems in formulation and do not know exactly the active ingredients, so they have the same effect when manufacturing products. It is difficult to expect and the possibility of containing unwanted components in the extract cannot be excluded.

한편 본 발명자들은 닥나무 추출물이 미백효과를 가짐을 확인하고 이에 관한 특허출원을 한바 있고 (특허공개 제92-021129호 및 92-1218), 이 닥나무속 식물의 유효 성분에 대한 연구를 계속하던 중 그 물질을 순수분리하여 동정하고 그 특성과 추가적인 효과를 알아내어 본 발명을 완성하기에 이르렀다.On the other hand, the present inventors have confirmed that the extract of the mulberry has a whitening effect and has applied for a patent (Patent Publication Nos. 92-021129 and 92-1218), and while continuing to study the active ingredient of the The material has been identified by pure separation and its properties and additional effects have been found to complete the present invention.

따라서, 본 발명은 목적은 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 분리 및 정제하는 방법을 제공하는 것이다.Accordingly, the present invention aims to isolate 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol and It is to provide a method for purification.

본 발명은 다른 목적은 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유하는 피부 미백용 조성물을 제공하는 것이다.Another object of the present invention is the skin containing 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol It is to provide a composition for whitening.

본 발명은 또다른 목적은 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유하는 항산화 조성물을 제공하는 것이다.Another object of the present invention is to contain 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol It is to provide an antioxidant composition.

본 발명의 또다른 목적은 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 첨가함을 특징으로 하는 식품, 화장료 조성물 또는 의약 조성물의 갈변현상을 방지하는 방법을 제공하는 것이다.Another object of the invention is the addition of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol It is to provide a method for preventing browning phenomenon of food, cosmetic composition or pharmaceutical composition characterized in that.

본 발명의 또다른 목적은 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유하는 화장료 조성물을 제공하는 것이다.Another object of the invention is to contain 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol It is to provide a cosmetic composition.

이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명에서 유효성분으로 사용되는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올 성분은 일본의 노무라 등이 닥나무(Broussonetia Kazinoki)의 근피로부터 분리한 여러 종의 이소프레에닐레이티드 1,3-디페닐프로판 유도체의 한 종류로서 [Chem. Pharm. Bull., 34(5) pp 1968-1979(1986)], 이 화합물이 티로시나제 활성 억제, 폴리페노옥시다제 활성 억제 및 항산화 작용을 갖는 것은 본 발명자들에 의해 최초로 규명되었다.5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol component used as an active ingredient in the present invention Nomura et al., Japan, is one of several isoprenenylated 1,3-diphenylpropane derivatives isolated from the roots of Broussonetia Kazinoki [Chem. Pharm. Bull., 34 (5) pp 1968-1979 (1986)], it was first identified by the present inventors that the compound has tyrosinase activity inhibition, polyphenooxidase activity inhibition and antioxidant activity.

본 발명에 따르면, 닥나무속 식물로부터 티로시나제 활성 억제효과가 뛰어나고 항산화력이 강력한 천연의 미백물질인 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 분리 정제방법이 제공된다. 노무라 등에 의해 공지된 분리방법은 조제용(Preparative) TLC를 이용한 분리방법으로서 많은 양을 분리해낼 수 없는 단점이 있으나 본 발명자 등은 용매분배와 일련의 컬럼 크로마토그래피 방법을 이용하여 우리나라에 널리 분포하는 닥나무속 식물의 줄기나 뿌리껍질로부터 다량으로 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 분리 및 정제할 수 있는 방법을 확립하였다.According to the present invention, 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-, which is a natural whitening substance having an excellent inhibitory effect on tyrosinase activity and a powerful antioxidant from the hawthorn plants A method for separating and purifying methyl-2-butenyl) -1,2-benzenediol is provided. The separation method known by Nomura et al. Has a disadvantage in that a large amount cannot be separated as a separation method using a preparative TLC, but the present inventors are widely distributed in Korea using solvent distribution and a series of column chromatography methods. 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzene in large amounts from the stem or root bark of the camphor A method by which diols can be isolated and purified has been established.

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 분리 정제방법을 보다 구체적으로 설명하면, 닥나무속 식물의 수피나 근피에 극성 용매, 예를 들면 에탄올, 메탄올, 프로판올, 아세톤 단독 또는 이들의 혼액을 가하고 실온에서 혹은 가열함으로써 추출을 행한다. 그 추출액을 농축하여 얻어진 추출물에 초산에틸, 톨루엔, 노르말 헥산 등의 지용성 용매와 물을 가하여 분배를 실시한다. 이때 지용성 용매층에 남은 물질에 대하여 세파덱스(Sephadex) LH-20 컬럼, 실리카 충진 컬럼 및 역상분배 컬럼, 예를 들면 옥타데실레이티드로 충진한 역상분배 컬럼인 리크로소브(Lichrosorb) RP-18 컬럼을 이용한 크로마토그래피를 다음과 같은 조건으로 항상화 작용, 티로시나제 활성을 억제하는 작용을 지표로 하여 순차적으로 실시하여 유효성분을 분리하고 그 물질을 재결정한다.The separation and purification method of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol will be described in more detail. Extraction is carried out by adding a polar solvent such as ethanol, methanol, propanol, acetone alone, or a mixture thereof to the bark and root bark of the hawthorn plant, and at room temperature or by heating. The extract is concentrated to add an oil-soluble solvent such as ethyl acetate, toluene, normal hexane, and water to the extract obtained. In this case, Licrosorb RP-18, which is a reverse phase distribution column filled with Sephadex LH-20 column, silica filled column, and reverse phase distribution column, for example, octadecylated, with respect to the material remaining in the fat-soluble solvent layer. Chromatography using a column is carried out sequentially with the following conditions as an indicator of homeostasis and inhibitory activity of tyrosinase activity to isolate the active ingredient and recrystallize the material.

* 컬럼 조건 :* Column Condition:

첫 번째 컬럼- 세파덱스(Sephadex) LH-20 충진 컬럼First column-Sephadex LH-20 packed column

(용매) 클로로포름 : 메탄올=1 : 1(Solvent) Chloroform: Methanol = 1: 1

두 번째 컬럼-실리카 충진 컬럼Second column-silica packed column

(용매) 클로로포름 : 메탄올=8 : 1(Solvent) Chloroform: Methanol = 8: 1

세 번째 컬럼-리크로소브(Lichrosorb) RP-18Third Column-Lichrosorb RP-18

(용매) 아세토니트릴 : 물(50:50)(Solvent) Acetonitrile: Water (50:50)

상기와 같은 방법으로 분리 및 정제한 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올은 다음과 같은 구조식을 갖는다.5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol isolated and purified in the same manner as described above It has the following structural formula.

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올은 티로시나제 활성 억제효과가 아주 뛰어나다. 즉, 버섯 티로시나제(mushroom tyrosinase) 활성을 50% 저해하는 농도인 IC50이 약 50μM로서, 지금까지 우수한 티로시나제 활성 억제물질로 알려진 코지산의 IC50이 약 100μM인 것을 감안하면 그의 티로시나제 활성 억제효과가 얼마나 탁월한지 알 수 있다.5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol has an excellent inhibitory effect on tyrosinase activity. In other words, IC 50 , a concentration that inhibits mushroom tyrosinase activity by 50%, is about 50 μM. Considering that IC 50 of kojic acid, known as an excellent tyrosinase inhibitor, is about 100 μM, its tyrosinase activity inhibition effect is about 50 μM. You can see how excellent it is.

따라서 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올은 효과적인 미백물질로 사용될 수 있다.Therefore, 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol can be used as an effective whitening material.

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올은 또한 탁월한 항산화 작용을 나타낸다. 이 물질의 항산화 효과는 DDPH 라디칼 소거 효과정도로 시험한 결과 IC50이 10μM정도로 나타나, 일반적인 항산화제로 사용되는 비타민 E(IC=35μM), 비타민 C(IC=30μM), 히드로퀴논(IC50=25μM) 보다 그의 항산화 효과가 우수한 물질임을 알 수 있다. 실제로 이 물질을 화장료나 연고기제에 배합시켜 피부안정성, 미백(美白)효과 및 피부 흑화 방지효과를 실험한 결과 피부에 안전하고 유의적인 미백효과를 갖음을 확인했다.5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol also shows excellent antioxidant activity. Antioxidant effect of this substance has IC 50 was tried so DDPH radical scavenging effect appeared about 10μM, more general vitamin E (IC = 35μM) is used as an antioxidant, vitamin C (IC = 30μM), hydroquinone (IC 50 = 25μM) It can be seen that its antioxidant effect is excellent material. In fact, this material was formulated into cosmetics and meat products to test skin stability, whitening effect, and skin blackening, and it was confirmed that it had a safe and significant whitening effect on skin.

그리고 식물성 식품에는 폴리페놀 화합물이 함유되어 있어 이들이 폴리페놀옥시다제에 의해서 산화가 촉진되어 갈변이라고 하는 변색현상을 일으킨다. 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올은 갈변현상에 관여하는 효소인 폴리페놀옥시다제의 활성을 저해하는 작용을 갖기 때문에 식품의 변색방지를 위한 식품첨가물로서 응용이 가능하다.In addition, polyphenol compounds are contained in plant foods, which promote oxidation by polyphenol oxidase and cause discoloration called browning. 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol is a polyphenol, an enzyme involved in browning Since it has a function of inhibiting the activity of oxidase, it can be applied as a food additive for preventing discoloration of food.

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 상기 목적, 즉 미백 효과, 항산화 작용 및 갈변방지를 위하여 사용하는 경우, 그의 첨가량은 사용 목적, 제품의 제형이나 용도에 따라 상이하며, 당업자가 용이하게 결정할 수 있지만, 예를 들면 최종 조성물 총중량에 대하여 0.01∼50%의 양으로 사용될 수 있다.5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol for this purpose, namely whitening effect, antioxidant action And when used for browning prevention, the amount thereof added varies depending on the purpose of use, the formulation or use of the product, and can be easily determined by those skilled in the art, but may be used, for example, in an amount of 0.01 to 50% based on the total weight of the final composition. have.

이하, 실시예들을 통해 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail with reference to examples.

[실시예 1]Example 1

닥나무(Broussonetia Kazinoki)의 근피(Root bark)를 풍건한 것 300g에 95% 수용성 에탄올 2000ml를 가하고 70℃에서 4시간 동안 가열하였다. 이어서 여과하여 여과액을 얻은 후 그 액을 증발시킨 후에 얻은 추출물 약 38g에 물과 에틸아세테이트 각 500ml를 가하고 분배하여 에틸아세테이트층을 얻었다. 이 에틸아세테이트층을 증발시켜 얻은 물질 약 24g에 대하여 세파덱스(Sephadex) LH 20 충진 컬럼(용매 ; 클로로포름 : 메탄올=1:1) , 컬럼-실리카 충진 컬럼(용매; 클로로포름 : 메탄올=8:1) 및 리크로소브(Lichrosorb) RP-18 컬럼(용매; 아세토니트릴 : 물=50:50)을 이용한 크로마토그래피를 실시하였다. 목적 물질이 함유된 최종 분획을 증발시키고 벤젠에서 재결정하여 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 약1.1g을 제조하였다. (수율 0.37%)Root bark of Burberrys (Broussonetia Kazinoki) was added to 300 g of air-dried 2000 ml of 95% aqueous ethanol and heated at 70 ° C. for 4 hours. Subsequently, filtrate was obtained, and the solution was evaporated. 500 ml of water and ethyl acetate were added to about 38 g of the extract, and the mixture was partitioned to obtain an ethyl acetate layer. Sepadex LH 20 packed column (solvent; chloroform: methanol = 1: 1) and column-silica packed column (solvent; chloroform: methanol = 8: 1) were applied to about 24 g of the material obtained by evaporating the ethyl acetate layer. And chromatography using a Lichrosorb RP-18 column (solvent; acetonitrile: water = 50: 50). The final fraction containing the desired material was evaporated and recrystallized from benzene to give 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1, About 1.1 g of 2-benzenediol was prepared. (Yield 0.37%)

[실시예 2]Example 2

꾸지나무(Broussonetia Paphrifera)의 근피(Root bark)를 풍건한 것 300g에 아세톤 2000ml를 가하고 실온에서 7일간 침적한 후, 여과하여 그 여과액을 얻은 후 그 액을 증발시켜 얻은 추출물 약 32g에 물과 노르말헥산 각 500ml를 가하고 분배하여 그 노르말헥산층을 얻었다. 이 노르말헥산층을 증발시켜 얻은 물질 약 19g에 대하여 실시예 1과 동일하게 크로마토그래피를 실시하였다. 목적 물질이 함유된 최종 분획을 증발시키고 벤젠에서 재결정하여 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 약 1.2g을 제조하였다. (수율 0.4%).Root bark of Broussonetia Paphrifera was added to 300 g of acetone, and 2000 ml of acetone was added thereto and then immersed at room temperature for 7 days. The filtrate was filtered, and the filtrate was evaporated. Each 500 ml of normal hexane was added and distributed, and the normal hexane layer was obtained. Chromatography was carried out in the same manner as in Example 1 with respect to about 19 g of the material obtained by evaporating the normal hexane layer. The final fraction containing the desired material was evaporated and recrystallized from benzene to give 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1, About 1.2 g of 2-benzenediol was prepared. (Yield 0.4%).

[실시예 3]Example 3

닥나무(Broussonetia Kazinoki)의 근피(Root bark)를 풍건한 것 300g에 95% 수용성프로판올 2000ml를 가하고 70℃에서 4시간 동안 가열하였다. 이어 여과하여 여과액을 얻은 후 그 액을 증발시켜 얻은 추출물 약 31g에 물과 톨루엔 각 500ml를 가하고 분배하여 톨루엔층을 얻었다. 이 톨루엔층을 증발시켜 얻은 물질 약 13g에 대하여 실시예 1과 동일하게 크로마토그래피를 실시하였다. 목적 물질이 함유된 최종 분획을 증발시키고 벤젠에서 재결정하여 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 약 0.6g을 제조하였다. (수율 0.2%).Root bark of Burberrys (Broussonetia Kazinoki) was added to 300 g of air dried 2000 ml of 95% water-soluble propanol and heated at 70 ° C. for 4 hours. Subsequently, filtrate was obtained to obtain a filtrate, and then 500 ml of water and toluene were added and distributed to about 31 g of the extract obtained by evaporation of the solution. About 13 g of the material obtained by evaporating this toluene layer was chromatographed similarly to Example 1. The final fraction containing the desired material was evaporated and recrystallized from benzene to give 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1, About 0.6 g of 2-benzenediol was prepared. (Yield 0.2%).

[실시예 4]Example 4

구조 분석Structural analysis

실시예 1에서 얻은 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 구조를 규명하기 위한 기기분석을 실시하였다.To identify the structure of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol obtained in Example 1 Instrumental analysis was performed.

녹는점 측정에는 코마 후버 모세관 녹는점 장치(Thoma Hoover Capillary melting point apparatus)를, UV 스펙트럼은 세실(Cecil) 5501 UV 분광광도계를, IR 스펙트럼은 바이오-레드(BIO-RAD) FTS-40 분광계를,1H 및13C-NMR 스펙트럼은 브룩커(Brucker) AM 500 분광계를, 그리고 MS 스펙트럼은 VG Trio-2(Unit 2,000AMU)을 이용하여 각각 측정하였다.Melting point measurements include the Coma Hoover Capillary melting point apparatus, the UV spectrum is the Cecil 5501 UV spectrophotometer, the IR spectrum is the Bio-Red FTS-40 spectrometer, 1 H and 13 C-NMR spectra were measured using a Brookler AM 500 spectrometer and MS spectra using a VG Trio-2 (Unit 2,000 AMU).

그 결과는 다음과 같으며, 실시예 2∼4에서 얻은 물질도 모두 동일한 결과를 나타내었다.The results are as follows, and the materials obtained in Examples 2 to 4 also showed the same results.

녹는점 : 108∼109℃Melting Point: 108 ~ 109 ℃

UV λmax 에탄올(log ε) : 283.7(2.457)UV λ max ethanol (log ε): 283.7 (2.457)

IR νmaxcm-1(KBr) : 3650.6, 3502.0, 1609.1IR ν max cm -1 (KBr): 3650.6, 3502.0, 1609.1

1H-NMR(DMSO-ds) :δ, ppm from TMS 6.21(1H, d, J=8㎐), 6.35(1H, s), 6.87(1H, d, J=8㎐) 1 H-NMR (DMSO-d s ): δ, ppm from TMS 6.21 (1H, d, J = 8 Hz), 6.35 (1H, s), 6.87 (1H, d, J = 8 Hz)

13C-NMR(DMSO-ds) : ppm 17.7, 17.7, 25.2, 25.4, 25.4, 27.0, 29.2, 31.7, 32.3, 102.3, 105.7, 113.6, 118.6, 124.0, 124.6, 126.8, 128.2, 129.4, 129.6, 129.8, 130.7, 141, 142.5, 155.7, 156.1 13 C-NMR (DMSO-d s ): ppm 17.7, 17.7, 25.2, 25.4, 25.4, 27.0, 29.2, 31.7, 32.3, 102.3, 105.7, 113.6, 118.6, 124.0, 124.6, 126.8, 128.2, 129.4, 129.6, 129.8, 130.7, 141, 142.5, 155.7, 156.1

MS m/z : 340, 204, 189, 161, 123, 69MS m / z: 340, 204, 189, 161, 123, 69

[시험예 1][Test Example 1]

티로시나제 활성효과Tyrosinase Activity

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 티로시나제 활성 저해효과를 다음과 같이 측정하여 닥나무 뿌리 조추출물, 초산에틸 가용성 추출물, 아스콜빈산 및 코지산의 효과와 비교하였다.Inhibition of tyrosinase activity of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol was determined as follows. It was compared with the effect of crude root extract, ethyl acetate soluble extract, ascorbic acid and kojic acid.

1) 실험방법1) Experiment Method

0.3㎎/㎖ 티로신 수용액, 0.1몰 농도 포타슘-포스페이트 완충용액(pH 6.8)을 각각 1.0㎖씩 시험관에 넣고, 적당 농도의 시험하고자 하는 티로시나제 활성 억제제를 0.9㎖를 시험군에, 대조군에는 티로시나제 활성억제제를 녹인 용매만을 넣는다. 이들을 잘 섞은 뒤에 버섯류 유래의 티로시나제(시그마사 제품 : 2,000유니트/㎖)용액 0.1㎖씩을 넣고 37℃ 항온조에서 10분간 반응시킨 뒤에 얼음물속에 시험관을 담가 반응을 중지시키고 흡광광도계로 475㎚에서 흡광도를 측정하였다. 측정된 흡광도에 대하여 다음의 식을 이용 티로시나제 활성 억제효과를 측정하였다.A 0.3 mg / mL aqueous solution of tyrosine and 0.1 mol of potassium-phosphate buffer solution (pH 6.8) were each added to the test tube, and 0.9 mL of the appropriate concentration of tyrosinase activity inhibitor to be tested was added to the test group, and the control group was tyrosinase activity inhibitor. Put only the dissolved solvent. After mixing well, add 0.1 ml of each solution of mushroom-derived tyrosinase (Sigma Co., Ltd .: 2,000 units / ml), and react for 10 minutes in a 37 ° C thermostat. It was. With respect to the measured absorbance, the tyrosinase activity inhibitory effect was measured using the following equation.

2) 실험결과2) Experiment result

IC(50% 억제 농도) : 반응계에서 반응을 50% 저해시키는 시료의 양 IC (50% inhibitory concentration): the amount of sample that inhibits the reaction by 50% in the reaction system

[시험예 2][Test Example 2]

항산화 효과Antioxidative effect

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 항산화 효과를 다음과 같이 측정하고 기존에 알려진 항산화제인 히드로퀴논, 비타민 E, 아스콜빈산, 카페익산, 3,4-디히드록시 벤조산 등의 효과와 비교하였다.The antioxidant effect of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol was measured as follows. It was compared with the effects of known antioxidants such as hydroquinone, vitamin E, ascorbic acid, caffeic acid, 3,4-dihydroxy benzoic acid.

1) 실험방법1) Experiment Method

100μM DPPH(디페닐 피크릴 히드라질 : Dipheny1 picryl Hydrazile) 에탄올 용액 1.9㎖에 적당 농도의 시험하고자 하는 시료용액을 0.1㎖를 넣고 37℃에서 30분간 반응시켰다. 반응 후에 반응액의 흡광도를 흡광 광도계로 515㎚에서 측정하였다.Into a 100 μM DPPH (Dipheny1 picryl Hydrazile) ethanol solution, 1.9 ml of a sample solution to be tested at a suitable concentration was added and reacted at 37 ° C. for 30 minutes. After the reaction, the absorbance of the reaction solution was measured at 515 nm with an absorbance photometer.

2) 실험결과2) Experiment result

[시험예 3][Test Example 3]

피부안전성Skin safety

피부안전성을 시험하기 위하여 건강한 성인 남녀 20명(남자 10명, 여자 10명)에 대하여 인체 첩포시험을 다음과 같이 실시하였다.In order to test the skin safety, a human patch test was performed on 20 healthy men and women (10 males, 10 females) as follows.

1) 실험방법1) Experiment Method

시험 대상자의 전박부를 70% 에탄올로 잘 닦은 다음 그 부위에 후술하는 제제예 7과 동일한 화장료 기제에 실시예 1∼3에서 분리한 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 0.2% (건조중량)의 양으로 비합시킨 영양크림 시료(4~6) 및 실시예 1중 에탄올 조추출물 1% 및 초산에틸 추출물 1%를 함유시킨 영양크림 시료(시료번호 2 및 3) 20마이크로리터씩 담은 핀 챔버(Finn Chamber)를 점착 테이프를 이용하여 24시간 폐쇄부착시켰다. 대조군(시료 번호 1)으로는 상기한 유효물질을 전혀 함유하지 않는 화장료 기제를 사용하였다. 24시간 후에 점착테이프와 핀 챔버를 제거하고, 가제로 피부에 잔존된 시료를 가볍게 닦아 제거한 뒤에 피부상태(홍반, 부종, 구진)를 관찰하고 다시 24시간 후에 한 번 더 관찰하였다.5- (3- (2,4-dihydroxyphenyl) propyl) separated in Examples 1 to 3 on the same cosmetic base as Formulation Example 7 described later, after wiping the forearm of the test subject with 70% ethanol well. Nourishing cream sample (4-6) and ethanol bath in Example 1, wherein -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol was combined in an amount of 0.2% (dry weight) A Finn Chamber containing 20 microliters of nourishing cream samples (Sample Nos. 2 and 3) containing 1% of extract and 1% of ethyl acetate extract was closed and attached for 24 hours using an adhesive tape. As a control (Sample No. 1), a cosmetic base containing no active substance described above was used. After 24 hours, the adhesive tape and the pin chamber were removed, and the sample remaining on the skin with a gauze was lightly removed. Then, the skin condition (erythema, edema, papules) was observed, and again after 24 hours.

2) 시험결과2) Test result

주) *=양성반응을 나타낸 대상의 수/총 실험대상의 수*) Number of subjects who showed positive response / total number of test subjects

위 표에서 알 수 있는 바와 같이 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유하는 본 발명의 크림은 인체피부에 자극성이 전혀 없는 것으로 확인되었다.As shown in the table above it contains 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol The cream of the present invention was confirmed to have no irritation to human skin.

[시험예 4][Test Example 4]

색소침착 억제 효과Pigmentation inhibitory effect

1) 실험방법1) Experiment Method

건강한 남녀 20명의 실험대상자의 양팔 하박부에 2×2㎠의 부위를 설정하였다. 실험 대상 부위에만 자외선이 조사되도록 알루미늄 호일을 팔에 씌우고 10㎝의 거리에서 일본 도시바(주) 제 FL20S BLB 램프 및 FL20S E-30램프를 각 2개 동시에 0.8×10 erg/㎤/회로 1일 1회씩 연속 3회 조사하였다. 조사전에 실험 대상 부위를 70%를 이소프로필알코올 수용액을 잘 세척하였다. 조사후 자외선 조사 부위에 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유한 제제예 9의 화장료를 1일에 3회씩 도포하였다. 4주간 도포후에 육안으로 색소침착 정도를 측정하여 처리군이 대조군에 비해 색소침착을 어느정도 억제하였는가를 현저한 효과, 유효, 무효의 3단계로 평가하였다.A region of 2 × 2 cm 2 was set in the lower arms of both arms of 20 healthy men and women. Put the aluminum foil on the arm so that the ultraviolet ray is irradiated only on the test target area, and at the distance of 10cm, at the same time 0.8 × 10 erg / cm 3 / circuit was examined three times in a row once daily. 70% of the test subjects were well washed with an isopropyl alcohol solution before irradiation. Preparation containing 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol at the site of ultraviolet irradiation after irradiation The cosmetic of Example 9 was applied three times a day. After four weeks of application, the degree of pigmentation was measured by naked eye, and the treatment group inhibited pigmentation compared to the control group, and evaluated in three stages of remarkable effect, effectiveness, and invalidity.

2) 실험결과2) Experiment result

[시험예 5][Test Example 5]

안면부위에 기미가 있는 여자 20명에 대하여 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유한 크림의 기미 치유 효과를 다음과 같이 시험하였다.5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol for 20 women with blemishes on the facial area The blemish healing effect of the cream containing was tested as follows.

1) 실험방법1) Experiment Method

안면에 기미가 있고 다른 피부질환은 없는 20∼50대의 여성 실험대상자 20명에게 안면의 좌측 부위에는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유하지 않은 크림(대조)을, 그리고 우측 부위에는 제제예 9의 크림을 8주 동안 1일 2회씩 도포하게 한 뒤 그 결과를 육안으로 관찰하였다. 관찰결과, 대조용 크림을 도포한 부위와 비교하여 제제예 9의 크림을 도포한 부위의 기미 부위의 탈색정도를 현저한 효과, 유효, 무효의 3단계로 평가하였다.Twenty female subjects in their 20s and 50s with facial signs and no other skin diseases had 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3) on the left side of the face. The cream (control) containing no methyl-2-butenyl) -1,2-benzenediol, and the cream of Formulation Example 9 were applied twice a day for 8 weeks on the right side, and the result was visually observed. Observed by. As a result of the observation, the degree of discoloration of the blemished portion of the cream-coated portion of Formulation Example 9 was evaluated in three stages of remarkable effect, effectiveness, and invalidity, compared with the control-coated portion.

2) 실험결과2) Experiment result

[시험예 6][Test Example 6]

폴리페놀옥시다제 활성억제효과측정Polyphenol oxidase activity inhibitory effect measurement

1) 실험방법1) Experiment Method

0.05M MES-NaOH 완충용액(pH 5.5) 2.0㎖, 에탄올에 녹인 0.5mM 시린가다진(syringadazine : 시그마사) 0.3㎖와 하기 표 6에 나타낸 폴리페놀옥시다제 활성 억제제를 포함한 에탄올 또는 수용액 0.5㎖ 그리고 시그마사로부터 구입한 라카제(Laccase) 효소 용액 0.2㎖(500units/㎖)을 섞어 30℃에서 5분간반응시킨 후 530㎚에서 흡광도를 측정하였다. 반응은 반응용액에 시린갈다진을 넣어줌으로써 시작하였다.2.0 ml of 0.05 M MES-NaOH buffer (pH 5.5), 0.5 ml of 0.5 mM syringadazine (Sigma) dissolved in ethanol and 0.5 ml of ethanol or aqueous solution containing polyphenol oxidase activity inhibitors shown in Table 6 and sigma 0.2 ml (500 units / ml) of the Lacase enzyme solution purchased from the company was mixed and reacted at 30 ° C. for 5 minutes, and the absorbance was measured at 530 nm. The reaction was initiated by adding cyringalazine to the reaction solution.

2) 실험결과2) Experiment result

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 농도를 달리하여 첨가하고, 이 물질을 첨가하지 않은 반응액을 대조군으로하여 효소활성 저해정도를 측정하였다. 그 결과 효소활성의 50%를 저해하는 농도인 IC=0.40μM을 구하였다(제8도).5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol is added at different concentrations, and this substance Inhibition of enzyme activity was measured using the reaction solution without the addition as a control. As a result, IC = 0.40 µM, which is a concentration that inhibits 50% of enzyme activity, was obtained (Fig. 8).

[시험예 7][Test Example 7]

갈변방지 활성Browning prevention activity

5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올이 갈변방지 작용을 다음과 같이 실험하여 평가하였다.5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol was tested for browning activity as follows. Evaluated.

1) 실험방법1) Experiment Method

사과 0.5㎏을 분쇄한 후 하루 정치한 다음 여과한 사과쥬스를 50g씩 나누어 다섯 분획을 한 뒤에 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 0, 1, 2, 4 또는 8μg씩 각각 첨가한 뒤 이 사과쥬스 분획들을 37℃ 항온실에서 보관하면서 경시적인 변색여부를 관찰하였다. 변색의 정도를 색차분광계(기기명 : Ultrascan spectrophotometer, 메이커 : Hunter Associates Laboratory, Inc)를 사용하여 △E 값을 비교 측정하였다. 여기서 △E =[(△L ) +(△a ) +(△b ) ] 를 나타낸다. 측정은 3회 실시하였고 그 평균치를 구하였다. 아래 표 6은 그 결과를 나타내었다. 첨가한 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 양에 비례하여 갈변현상이 현저하게 감소함을 알 수 있었다.After grinding 0.5kg of apples, they were allowed to stand for one day, and the filtrated apple juice was divided into 50 parts of 50 g each, and then fractions were divided into 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-). Methyl-2-butenyl) -1,2-benzenediol was added at 0, 1, 2, 4, or 8 μg, respectively, and the apple juice fractions were stored in a 37 ° C. constant temperature room to observe discoloration over time. The degree of discoloration was measured using a chrominance spectrophotometer (Ultrascan spectrophotometer, manufacturer: Hunter Associates Laboratory, Inc.) The values were compared and measured. Where △ E = [(△ L ) + (△ a ) + (△ b ) ] Indicates. The measurement was performed three times and averaged. Table 6 below shows the results. Browning phenomenon in proportion to the amount of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol added It can be seen that the decrease significantly.

[제제예 1-3][Example 1-3]

유연화장수(스킨 로션)Softener (Skin Lotion)

[제제예 4-6]Preparation Example 4-6

영양화장수(밀크킨 로션)Nourishing Cosmetic (Milkkin Lotion)

[제제예 7-9][Example 7-9]

영양크림Nutrition Cream

[제제예 10-12]Preparation Example 10-12

맛사지 크림Massage cream

[제제예 13-15]Preparation Example 13-15

pack

[제제예 16-18][Example 16-18]

연고Ointment

[제제예 19-21]Preparation Example 19-21

오일oil

Claims (5)

닥나무속 식물의 수피 또는 근피를 극성 용매를 이용하여 추출하는 단계, 추출액을 농축하여 농축 추출물을 얻고, 이 농축 추출물에 지용성 용매와 물을 가하여 분배를 실시하는 단계 및 지용성 용매층 분획에 대하여 세파덱스(Sephadex) LH-20 컬럼, 실리카 충진 컬럼 및 역상분배 컬럼을 순차적으로 실시하는 단계로 이루어짐을 특징으로 하는 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올의 분리 및 정제 방법.Extracting the bark or the bark of the hawthorn plant with a polar solvent, obtaining a concentrated extract by concentrating the extract, distributing it by adding a fat-soluble solvent and water to the concentrated extract and separating the fat-soluble solvent layer from the Sephadex (Sephadex) 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis, comprising the steps of sequentially performing an LH-20 column, a silica packed column and a reverse phase distribution column Separation and Purification Method of (3-methyl-2-butenyl) -1,2-benzenediol. 제1항에 있어서, 컬럼의 조건은 첫 번째 컬럼은 세파덱스(Sephadex) LH 20 충진 컬럼으로서 용매는 클로로포름 : 메탄올(1:1) 혼합물이고, 두 번째 컬럼인 실리카 충진 컬럼의 용매는 클로로포름 : 메탄올(8:1) 혼합물이며, 세 번째 역상 분배 컬럼은 리크로소브(Lichrosorb) RP-18 컬럼으로서 용매는 아세토니트릴 : 물(50 : 50) 혼합물임을 특징으로 하는 분리 및 정제 방법.The method of claim 1, wherein the first column is a Sephadex LH 20 packed column, the solvent is a chloroform: methanol (1: 1) mixture, and the second column, the silica packed column is chloroform: methanol. (8: 1) mixture, and the third reverse phase distribution column is a Lichrosorb RP-18 column, wherein the solvent is an acetonitrile: water (50:50) mixture. 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유하는 피부 미백용 조성물.A composition for skin whitening containing 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol. 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 함유하는 항산화 조성물.An antioxidant composition containing 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol. 5-(3-(2,4-디히드록시페닐)프로필)-3,4-비스(3-메틸-2-부테닐)-1,2-벤젠디올을 첨가함을 특징으로 하는 식품, 화장료 조성물 또는 의약 조성물의 갈변현상을 방지하는 방법.Foods and cosmetics characterized by the addition of 5- (3- (2,4-dihydroxyphenyl) propyl) -3,4-bis (3-methyl-2-butenyl) -1,2-benzenediol A method of preventing browning of a composition or a pharmaceutical composition.
KR1019940007603A 1994-04-12 1994-04-12 Separation method for 5-(3-(2-4-dihydroxy phenyl)propyl)-3,4- bis (3-methyl-2-butenyl)-1,2-benzenediol KR970010460B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940007603A KR970010460B1 (en) 1994-04-12 1994-04-12 Separation method for 5-(3-(2-4-dihydroxy phenyl)propyl)-3,4- bis (3-methyl-2-butenyl)-1,2-benzenediol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940007603A KR970010460B1 (en) 1994-04-12 1994-04-12 Separation method for 5-(3-(2-4-dihydroxy phenyl)propyl)-3,4- bis (3-methyl-2-butenyl)-1,2-benzenediol

Publications (2)

Publication Number Publication Date
KR950029247A KR950029247A (en) 1995-11-22
KR970010460B1 true KR970010460B1 (en) 1997-06-26

Family

ID=19380841

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940007603A KR970010460B1 (en) 1994-04-12 1994-04-12 Separation method for 5-(3-(2-4-dihydroxy phenyl)propyl)-3,4- bis (3-methyl-2-butenyl)-1,2-benzenediol

Country Status (1)

Country Link
KR (1) KR970010460B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120083943A (en) * 2010-08-13 2012-07-27 (주)아모레퍼시픽 Composition of skin external application containing propanoid derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120083943A (en) * 2010-08-13 2012-07-27 (주)아모레퍼시픽 Composition of skin external application containing propanoid derivatives

Also Published As

Publication number Publication date
KR950029247A (en) 1995-11-22

Similar Documents

Publication Publication Date Title
KR20020086326A (en) Extract of Rosa multiflora with antioxdative activity, process for preparation thereof and composition containing thereof
KR101083275B1 (en) Whitening agent skin preparation for external use and cosmetic
WO2016110276A1 (en) Topical composition containing obakunone and skin-whitening method using same
KR101220494B1 (en) Cosmetic Composition for Skin Whitening Comprising Liriope Seed Extracts
KR20070079638A (en) Extracts from zizyphus jujuba var. inermis rehder for antioxidation and functional food containing the same
US10695283B2 (en) Extract of Greyia radlkoferi and use thereof
KR970010460B1 (en) Separation method for 5-(3-(2-4-dihydroxy phenyl)propyl)-3,4- bis (3-methyl-2-butenyl)-1,2-benzenediol
JP2002249772A (en) Antioxidant and composition including the same
KR20210134589A (en) Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom
KR100453217B1 (en) Skin whitener
KR101966755B1 (en) Composition for skin-lightening or antioxidant containing extract of Jeju camellia mistletoe
FR2950532A1 (en) PROCESS FOR THE PREPARATION OF AN EXTRACT OF PLANTS OF THE GENUS SCLEROLOBIUM, COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING THIS EXTRACT AND THE USE OF SAID EXTRACT
KR102313083B1 (en) An anti-oxidative composition comprising an extract of Hydrangea petiolaris or a fraction thereof as an active ingredient
KR20030020811A (en) Whitening cosmetics containing natural extracts
KR0147412B1 (en) Whitening cosmetics containing purified morus marus cortex, fructus extract and kojic acid
KR100935329B1 (en) Fruit extract of rubus hirsutus thunb. having skin whitening activity containing ellagic acid
JP3597068B2 (en) Antioxidant and composition containing the same
KR100535264B1 (en) Skin whitening composition containing pentachoea extract
KR20010057776A (en) Skin whitening agent
JP2000198726A (en) Agent for suppressing formation of lipid peroxide and composition containing the agent
KR20110066042A (en) Cosmetic composition comprising unripe apple extracts
KR100454115B1 (en) Method for Separating 1,2-di-o-feruloylglycerol and Cosmetic Composition Containing the Same and its Use
KR0120277B1 (en) Skin whitening compositions comprising 4-hydroxy-5-methyl-3(2h)-furanone
KR20230006131A (en) Cosmetic composition having skin whitening effect
JP3597067B2 (en) Antioxidant and composition containing the same

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120515

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20130531

Year of fee payment: 17

EXPY Expiration of term